Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2025-12-29 @ 12:03 PM
Study NCT ID:
NCT00675857
Status:
COMPLETED
Last Update Posted:
2010-08-24
First Post:
2008-05-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes
Sponsor:
Bellus Health Inc. - a GSK company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2010-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-05
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-08
First Submit QC Date:
None
Study First Post Date:
2008-05-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-08-23
Last Update Post Date:
2010-08-24
Last Update Post Date Type:
ESTIMATED